Help - Search - Members - Calendar
Full Version: PVD
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Cardiology > PVD
Pages: 1, 2, 3
  1. Medistem publishes positive preclinical data on menstrual derived stem cells (0 replies)
  2. Litigation claims in vascular surgery in the united kingdom's nhs. (0 replies)
  3. Acute type ii cryoglobulinaemic vasculitis mimicking atherosclerotic peripheral vascular disease (0 replies)
  4. Medistem inc.: medistem publishes positive preclinical data on menstrual derived stem cells (0 replies)
  5. Limbs saved by menstrual blood stem cells (0 replies)
  6. Limbs saved by menstrual blood stem cells (0 replies)
  7. Allogeneic endometrial regenerative cells: an "off the shelf solution" for critical limb ischemia? (0 replies)
  8. Limbs saved by menstrual blood stem cells (0 replies)
  9. Lemaitre vascular to present at canaccord adams 28th annual global growth conference (0 replies)
  10. Gene therapy for coronary and peripheral artery disease (0 replies)
  11. Co-delivery of fgf-2 and g-csf from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. (0 replies)
  12. Verrucous carcinoma of the foot: a case report. (0 replies)
  13. [ambulatory, ct-assisted lumbar sympathicolysis in patients with severe peripheral artery disease: influence on peripheral blood flow and clinical outcome.] (0 replies)
  14. [original contributions] mortality in open heart surgery with intraaortic balloon pump support (0 replies)
  15. Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice (0 replies)
  16. Aortoduodenal fistula and streptococcal myonecrosis (0 replies)
  17. Volcano corporation schedules second quarter conference call and webcast (0 replies)
  18. Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: comparison in a decision analysis model. (0 replies)
  19. Wound bioburden and infection-related complications in diabetic foot ulcers (0 replies)
  20. Effect of ginkgo biloba (egb 761) on treadmill walking time among adults with peripheral artery disease: a randomized clinical trial. (0 replies)
  21. Angioscore launches new longer and larger angiosculpt(r) devices for treatment of peripheral artery disease (0 replies)
  22. Peripheral contrast-enhanced mr angiography at 3.0t, improved spatial resolution and low dose contrast: initial clinical experience (0 replies)
  23. Angioscore launches new longer and larger angiosculpt(r) devices for treatment of peripheral artery disease (0 replies)
  24. New tool to help measure cardiovascular risk: cheaper, easier (0 replies)
  25. Elevated factor xiii level and the risk of peripheral artery disease. (0 replies)
  26. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis (0 replies)
  27. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. (0 replies)
  28. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. (0 replies)
  29. Clinical crossroads: a 70-year-old man with a transient ischemic attack: review of internal carotid artery stenosis (0 replies)
  30. Differences in gait characteristics between persons with bilateral transtibial amputations, due to peripheral vascular disease and trauma, and able-bodied ambulators. (0 replies)
  31. Reasons for blacks' higher prevalence of peripheral artery disease remain unexplained, study concludes (0 replies)
  32. Biomedix to open dubai facility (0 replies)
  33. Insulin resistance an independent predictor of peripheral artery disease (0 replies)
  34. 48yr old lady with histry of pvd and femoral angioplasty wants hrt. is topical short term safe for her (0 replies)
  35. Insulin resistance tied to peripheral artery disease (0 replies)
  36. Insulin resistance tied to peripheral artery disease (0 replies)
  37. Insulin resistance tied to peripheral artery disease (0 replies)
  38. Insulin resistance linked to peripheral artery disease (0 replies)
  39. New study finds wide disparities in medicare's quality of care (0 replies)
  40. Carbon monoxide may reduce skeletal muscle injuries, mouse study suggests (0 replies)
  41. The predictors of foot ulceration in patients with rheumatoid arthritis: a preliminary investigation (0 replies)
  42. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among african americans: the san diego population study (0 replies)
  43. Outback catheter-assisted simultaneous antegrade and retrograde access for subintimal recanalization of peripheral arterial occlusion. (1 reply)
  44. [medical_sciences] chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis (1 reply)
  45. Correspondence: local paclitaxel delivery in peripheral vascular disease (1 reply)
  46. A review of picotamide in the reduction of cardiovascular events in diabetic patients (1 reply)
  47. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels (1 reply)
  48. Volcano corporation presentation at jmp conference to be webcast (1 reply)
  49. Volcano reports 24 percent increase in first quarter revenues; ivus disposable revenues increase 30 percent (1 reply)
  50. Cell therapy trials approved (1 reply)
  51. Volcano corp announces first human use of the volcano optical coherence tomography (oct) imaging catheter (1 reply)
  52. [peripheral arterial disease--an underappreciated clinical problem] (1 reply)
  53. Sub-clinical vascular disease in type 2 diabetic subjects: relationship with chronic complications of diabetes and the presence of cardiovascular disease risk factors. (1 reply)
  54. Proteomics in atherosclerosis (1 reply)
  55. Early study results show new stem cell treatment successfully treats critical limb ischemia (cli) patients: first results of randomized, placebo-controlled, double-blinded study of cli; data presented at annual meeting of the german society (1 reply)
  56. Cordis corporation launches new peripheral angioplasty balloon catheters (1 reply)
  57. Gene silencing of cd47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. (1 reply)
  58. African americans have 5 times higher amputation rate (1 reply)
  59. African americans have five times higher rate of lower limb amputations (1 reply)
  60. African americans have five times higher amputation rate (1 reply)
  61. African americans have 5 times higher amputation rate (1 reply)
  62. Volcano corporation schedules first quarter conference call, webcast (1 reply)
  63. Extending the boundaries of no-touch aorta technique usage for coronary artery bypass grafting in patients with diseased ascending aorta. (1 reply)
  64. Excimer laser assisted angioplasty for complex infrainguinal peripheral artery disease: a 2008 update. (1 reply)
  65. Peripheral artery disease (pad) (1 reply)
  66. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life (1 reply)
  67. Intermittent pneumatic compression may save ischemic limb (1 reply)
  68. Pcsk9 variants associated with reduced prevalence of pad (1 reply)
  69. Nonvenomous bite injuries of the foot: case reports and review of the literature (1 reply)
  70. Impact of race on morbidity and mortality in patients with congestive heart failure: a study of the multiracial population in singapore. (1 reply)
  71. Complications of replacing implantable devices in response to advisories: a single center experience. (1 reply)
  72. Atypical ischemic lower extremity ulcerations: a differential diagnosis (1 reply)
  73. Peripheral artery disease common in hiv patients (1 reply)
  74. [surgery for acquired cardiovascular disease] early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients (1 reply)
  75. Volcano announces u.s. and european launch of rotational ivus and integrated ffr (1 reply)
  76. Volcano announces u.s. and european launch of rotational ivus and integrated ffr (1 reply)
  77. Landmark trial ontarget® proves telmisartan is as protective as ramipril and better tolerated in a broad high-risk cardiovascular population.
    from ontarget® it may be concluded that telmisartan can prevent every 5th serious cardiovascular even     (1 reply)
  78. [institutional report - coronary] early and mid-term results of off-pump coronary artery bypass grafting in patients with end stage renal disease: surgical outcomes after achievement of complete revascularization (1 reply)
  79. Recent advances in atherectomy and devices for treatment of infra-inguinal arterial occlusive disease. (1 reply)
  80. The foot in perspective (1 reply)
  81. A 62 yr type 2 diabetic has fasting cholesterol untreated of 3.9 and hdl of 1.1. should i start statin? (1 reply)
  82. New portable device aids in detecting peripheral vascular disease. (1 reply)
  83. Obesity as a predictor of vascular access outcomes: analysis of the usrds dmms wave ii study. (1 reply)
  84. Prognostic value of functional performance for mortality in patients with peripheral artery disease (1 reply)
  85. Vermillion biomarker panel potential aid in the diagnosis of peripheral artery disease (1 reply)
  86. Clinical outcome in patients with peripheral artery disease. results from a prospective registry (frena). (1 reply)
  87. Branding of vascular surgery (1 reply)
  88. Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease (1 reply)
  89. The role of antiendothelial cell antibodies in the development and follow-up of coronary and peripheral arterial diseases (1 reply)
  90. Sexual dissatisfaction linked to peripheral artery disease in women (1 reply)
  91. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease (1 reply)
  92. Einstein researchers find that vitamin d may protect against peripheral artery disease (1 reply)
  93. Vitamin d may protect against peripheral artery disease (1 reply)
  94. Vitamin d may protect against pad (1 reply)
  95. Cochrane review: oral vasodilators for primary raynaud's phenomenon (1 reply)
  96. Macrovascular disease and atherosclerosis in ssc (1 reply)
  97. Vitamin d may protect against peripheral artery disease (1 reply)
  98. Peripheral vascular disease (1 reply)
  99. Low vitamin d levels linked to increased risk of artery disease (1 reply)
  100. Low vitamin d levels associated with higher prevalence of peripheral artery disease (1 reply)
  101. Atherosclerosis: preventing a potential killer (1 reply)
  102. Percutaneous peripheral interventions in patients with non-st elevation acute coronary syndromes performed by interventional cardiologists: rationale and results. (1 reply)
  103. Limitations of clinical history for evaluation of patients with acute chest pain, non-diagnostic electrocardiogram, and normal troponin. (1 reply)
  104. Impaired flow-mediated endothelium-dependent and endothelium-independent vasodilation of the brachial artery in patients with atherosclerotic peripheral vascular disease (1 reply)
  105. Vermillion using stanford biomarker to assess artery disease (1 reply)
  106. Vermillion using stanford biomarker to assess artery disease (1 reply)
  107. Hemodialysis in patients older than 65 years with end-stage renal failure : comparison of outcome in patients with and without diabetes. (1 reply)
  108. Genetic mutation found in peripheral artery disease (0 replies)
  109. Discovery of genetic mutation in peripheral artery disease (0 replies)
  110. First patient enrolled in study evaluating performance of spectranetics laser ablation followed by gore viabahn(r) endoprosthesis with heparin bioactive surface (0 replies)
  111. Many stroke, heart attack patients may not benefit from aspirin (0 replies)
  112. Genetic mutation may be link to pad (0 replies)
  113. Genetic mutation found in peripheral artery disease (0 replies)
  114. Genetic mutation linked to peripheral artery disease (0 replies)
  115. Aspirin does not benefit many stroke, heart attack patients (0 replies)
  116. Missed opportunities for reperfusion therapy for st-segment elevation myocardial infarction: results of the emergency department quality in myocardial infarction (edqmi) study. (0 replies)
  117. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. (0 replies)
  118. Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of nhanes 1999-2002 data. (0 replies)
  119. New way to reverse poor circulation and heal wounds discovered by researchers (0 replies)
  120. Social cognitive constructs and the promotion of physical activity in patients with peripheral artery disease. (0 replies)
  121. Original article: changes in the use of carotid revascularization among the medicare population (0 replies)
  122. Need for late lower limb revascularization and major amputation after coronary artery bypass surgery. (0 replies)
  123. Complications of diabetes in urban indigenous australians: the druid study. (0 replies)
  124. Impaired hyperaemic and rhythmic vasomotor response in type 1 diabetes mellitus patients: a predictor of early peripheral vascular disease. (0 replies)
  125. Hypertension, ras, and gender: what is the role of aminopeptidases? (0 replies)
  126. Emea recommends new warnings and contraindications for rosiglitazone (0 replies)
  127. [work in progress report - assisted circulation] extended duration of brachially inserted intra-aortic balloon pump for myocardial protection in two patients undergoing urgent coronary artery bypass grafting (0 replies)
  128. Determinants of endothelial function in a cohort of patients with peripheral artery disease (0 replies)
  129. Severity of peripheral artery disease may be better gauged by global positioning tracker (0 replies)
  130. Global positioning tracker may better gauge severity of peripheral artery disease (0 replies)
  131. Gps devices measure severity of peripheral artery disease (0 replies)
  132. Gps devices measure severity of peripheral artery disease (0 replies)
  133. Study looks at off-label use of biliary stents (0 replies)
  134. Study looks at off label use of biliary stents (0 replies)
  135. Study looks at off-label use of biliary stents (0 replies)
  136. Procedures treating peripheral artery disease to grow more than 70% in total by 2012 (0 replies)
  137. Vascular disease: majority of device malfunctions occur with off-label use of biliary stents, study suggests (0 replies)
  138. Consideration on prevention of phlebitis and venous pain from intravenous prostaglandin e(1) administration by adjusting solution ph: in vitro manipulations affecting ph. (0 replies)
  139. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy trial (create) biomarker sub-study (0 replies)
  140. Fibrinogen apheresis and peripheral vascular disease: some progress? (0 replies)
  141. Angiodynamics debuts new hemodialysis catheter (0 replies)
  142. Court denies diomed motion against angiodynamics (0 replies)
  143. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. (1 reply)
  144. Vital images' enterprise-wide advanced visualization and analysis technology showcased at new cardiovascular horizons conference (1 reply)
  145. Cost-utility analysis of a national project to reduce hypertension in israel (1 reply)
  146. [original articles: cardiovascular] long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease (1 reply)
  147. Modifiable risk factors remain significant causes of medium term mortality after first time coronary artery bypass grafting (1 reply)
  148. Coronary artery disease in patients with aortic aneurysm: a classification of 302 coronary angiograms and results of surgical management (1 reply)
  149. Ev3 introduces two new enhanced offerings for the treatment of peripheral artery disease (1 reply)
  150. Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction. (1 reply)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.